191 related articles for article (PubMed ID: 23764681)
1. Advances in the management of recurrent endometrial cancer.
Bradford LS; Rauh-Hain JA; Schorge J; Birrer MJ; Dizon DS
Am J Clin Oncol; 2015 Apr; 38(2):206-12. PubMed ID: 23764681
[TBL] [Abstract][Full Text] [Related]
2. Treatment options for advanced endometrial carcinoma.
Dizon DS
Gynecol Oncol; 2010 May; 117(2):373-81. PubMed ID: 20223510
[TBL] [Abstract][Full Text] [Related]
3. Recurrent endometrial cancer.
Del Carmen MG; Boruta DM; Schorge JO
Clin Obstet Gynecol; 2011 Jun; 54(2):266-77. PubMed ID: 21508696
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant treatment of advanced-stage endometrial cancer.
Lee NK
Clin Obstet Gynecol; 2011 Jun; 54(2):256-65. PubMed ID: 21508695
[TBL] [Abstract][Full Text] [Related]
5. Management of advanced-stage and recurrent endometrial cancer.
Ray M; Fleming G
Semin Oncol; 2009 Apr; 36(2):145-54. PubMed ID: 19332249
[TBL] [Abstract][Full Text] [Related]
6. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
7. Systemic therapy in metastatic or recurrent endometrial cancer.
Pectasides D; Pectasides E; Economopoulos T
Cancer Treat Rev; 2007 Apr; 33(2):177-90. PubMed ID: 17196749
[TBL] [Abstract][Full Text] [Related]
8. Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.
Milgrom SA; Kollmeier MA; Abu-Rustum NR; Tew WP; Sonoda Y; Barakat RR; Alektiar KM
Gynecol Oncol; 2013 Sep; 130(3):436-40. PubMed ID: 23800696
[TBL] [Abstract][Full Text] [Related]
9. The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
McMeekin DS; Filiaci VL; Thigpen JT; Gallion HH; Fleming GF; Rodgers WH;
Gynecol Oncol; 2007 Jul; 106(1):16-22. PubMed ID: 17574073
[TBL] [Abstract][Full Text] [Related]
10. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
Gadducci A; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
[TBL] [Abstract][Full Text] [Related]
11. Current treatment options for endometrial cancer.
Santin AD; Bellone S; O'Brien TJ; Pecorelli S; Cannon MJ; Roman JJ
Expert Rev Anticancer Ther; 2004 Aug; 4(4):679-89. PubMed ID: 15270671
[TBL] [Abstract][Full Text] [Related]
12. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
[TBL] [Abstract][Full Text] [Related]
13. Management of recurrent endometrial carcinoma.
Kao MS
Chang Gung Med J; 2004 Sep; 27(9):639-45. PubMed ID: 15605903
[TBL] [Abstract][Full Text] [Related]
14. Update in the management of endometrial cancer.
Levine DA; Hoskins WJ
Cancer J; 2002; 8 Suppl 1():S31-40. PubMed ID: 12075700
[TBL] [Abstract][Full Text] [Related]
15. Gynecologic malignancies.
Schilder RJ; Scher RM; Young RC
Cancer Chemother Biol Response Modif; 1993; 14():530-56. PubMed ID: 8312118
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant treatment for endometrial cancer: literature review and recommendations by the Comité de l'évolution des pratiques en oncologie (CEPO).
Morneau M; Foster W; Lalancette M; Van Nguyen-Huynh T; Renaud MC; Samouëlian V; Letarte N; ; ; Almanric K; Boily G; Bouchard P; Boulanger J; Cournoyer G; Couture F; Gervais N; Goulet S; Guay MP; Kavanagh M; Lemieux J; Lespérance B; Letarte N; Morneau M; Ouellet JF; Pineau G; Rajan R; Roy I; Samson B; Sidéris L; Vincent F
Gynecol Oncol; 2013 Oct; 131(1):231-40. PubMed ID: 23872191
[TBL] [Abstract][Full Text] [Related]
17. Applicability of the concept of "platinum sensitivity" to recurrent endometrial cancer: the SGSG-012/GOTIC-004/Intergroup study.
Nagao S; Nishio S; Michimae H; Tanabe H; Okada S; Otsuki T; Tanioka M; Fujiwara K; Suzuki M; Kigawa J
Gynecol Oncol; 2013 Dec; 131(3):567-73. PubMed ID: 24076450
[TBL] [Abstract][Full Text] [Related]
18. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T;
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):168-73. PubMed ID: 15093913
[TBL] [Abstract][Full Text] [Related]
19. An unusual case of recurrent endometrial cancer presented with isolated cervical lymph node metastasis.
Bilici A; Karci E; Altun E; Ozkara SK; Uygun K; Aksu G; Ustaalioglu BB
Arch Gynecol Obstet; 2009 Jul; 280(1):153-6. PubMed ID: 19082834
[TBL] [Abstract][Full Text] [Related]
20. [Activity of paclitaxel, epirubicin and carboplatin in patients with advanced or recurrent endometrial cancer].
Nakashima R; Enomoto T; Murata Y; Fujita M
Nihon Rinsho; 2004 Oct; 62 Suppl 10():360-4. PubMed ID: 15535268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
